RE:Pfizer announces OS results from its Phase 3 mBC trialPfizer versus Roche in oncology .... Pfizer has become the most reputable pharma company for cancer patient groups, knocking Roche out of the top spot. Pfizer isn’t the biggest oncology player; that title goes to Roche. But Pfizer does have a fair few marketed cancer therapies, including breast cancer drug Ibrance; lung cancer drugs Vizimpro, Lorbrena and Xalkori; and kidney cancer therapies Sutent and Inlyta.
https://www.fiercepharma.com/marketing/pfizer-topples-oncology-giant-roche-cancer-patient-groups-reputation-list